NPM1 and acute myeloid leukemia: Perhaps the most important observation by a study comparing the survival outcomes of NPM1-mutated MS vs. NPM1-mutated AML was that OS was significantly shorter for NPM1-mutated MS (45 mos vs. 93 mos [81].